Faculty

Institution

Unit

Venue

David DeRemer

Clinical Professor

University of Florida

Affiliations

College of Pharmacy

Pharmacotherapy and Translational Research

David Deremer is currently serving as a College Of Pharmacy Clinical Professor at University of Florida.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

David DeRemer

University of Florida

Clinical Professor

You can click a keyword to filter the displayed items

oncology pharmacology medicine cancer treatment cancer research hematology cancer care clinical research pharmacotherapy radiation oncology medicinal research immunology clinical transplantation regenerative medicine transplantation medicine stem cell transplantation cancer immunotherapy cell transplantation cellular therapy hematological malignancies cancer biology cardiology organ transplantation bone marrow transplantation clinical pharmacology clinical pharmacy pharmaceutics leukemia medical mycology therapeutic efficacy anti-cancer agents respiratory medicine clinical microbiology pharmaceutical practice cell therapy tumor targeting enzyme inhibition multiple myeloma surgical oncology clinical medicine treatment effects phase ii study vascular biology avian medicine clinical therapeutics stem-cell therapy cerebrovascular disease drug treatment drug targeting liver cancer pharmaceutical sciences anticoagulants drug trials chemotherapy-induced nausea platelet recovery secondary failure novel therapies receptor tyrosine kinases cell regulation angiology clinical physiology angiogenesis benchmark studies antibody engineering clinical infectious disease antiangiogenic therapy chronic myelogenous leukemia systemic mastocytosis tyrosine kinase inhibitors granulocyte colony-stimulating factor novel induction therapies prostate cancer cells experimental evidence angiotensin receptor blockers metastatic breast cancer phase iii trial personalized medicine molecular diagnostics pharmacogenomics applied pharmacology preclinical drug evaluation supportive care

Video Presentations

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 4816: Racial Disparities in Adjunctive Supportive Care Medication Use in Pancreatic Cancer Patients. Cancer Research (2024)

Olga M. Trejos KweyeteYi GuoSherise C. RogersLisa ScartonDavid L. DeRemerChardae L. WhitnerDiana J. WilkieJohn M. Allen

medicinecancer carecancer researchpancreatic cancerhealth care disparitiesoncologyracial disparitiessupportive care

Abstract 4834: Racial Disparities in Pain and Psychiatric Medication Use in Patients With Metastatic Colorectal Cancer. Cancer Research (2024)

John M. AllenOlga M. Trejos KweyeteYi GuoSherise C. RogersLisa ScartonDavid L. DeRemerChardae WhitnerDiana J. Wilkie

medicinehealth disparitiespharmacologycancer carecancer paincancer researchmetastatic colorectal cancerpsychiatryoncologyracial disparitiescolorectal cancercancer treatmentpsychiatric medication usehealth care disparities

A Phase Ib/II Study of Atezolizumab Plus Tivozanib in Pancreatic, Gallbladder, and Bile Duct Malignancies.. Journal of Clinical Oncology (2024)

Brian Hemendra RamnaraignJi-Hyun LeeIlyas SahinSherise C. RogersRyan M. ThomasCarmen J. AllegraDavid L. DeRemerThomas J. GeorgeJonathan Alexander Chatzkel

hematological malignanciesdigestive diseasesradiologypharmacologycancer carethoracic oncologyradiation oncologycancer researchpancreatic cancercancer immunotherapybile duct malignanciesoncologyclinical researchgastrointestinal oncology

CAPIVASERTIB: A Novel Akt Inhibitor Approved for Hormone-Receptor-Positive, Her-2-Negative Metastatic Breast Cancer. Annals of Pharmacotherapy (2024)

Alexa J. LuboffDavid L. DeRemer

medicineenzyme inhibitionpharmacologymetastasiscancer researchpharmacotherapyanti-cancer agentsbreast canceroncologydrug targetingcancer treatmentclinical pharmacologydrug deliverynovel akt inhibitordrug targets

Implementation of a Pharmacogenetic Panel‐Based Test for Pharmacotherapy‐Based Supportive Care in an Adult Oncology Clinic. Clinical and Translational Science (2024)

Emily J. CicaliElizabeth EddyYan GongAmanda L. ElchynskiKim Pena del AguilaTala BashaKaren C. DailyLauren DicksonSteven FischerErin Hastings‐MonariDennie JonesBrian H. RamnaraignDavid L. DeRemerThomas J. GeorgeRhonda M. Cooper‐DeHoff

adult oncology clinicpharmacologypharmacogenetic panel-based testpharmacotherapyoncologyclinical researchpharmaceutical carepharmacotherapy-based supportive care

Phase II Trial of the Parp Inhibitor, Niraparib, in Bap1 and Other Dna Damage Response Pathway-Deficient Neoplasms. JCO Precision Oncology (2024)

Thomas J. GeorgeJi-Hyun LeeDavid L. DeRemerPeter J. HoseinSteven StaalMerry Jennifer MarkhamDennie JonesKaren C. DailyJonathan A. ChatzkelBrian H. RamnaraignJulia L. CloseNkiruka EzenwajiakuMartina C. MurphyCarmen J. AllegraSherise RogersZhongyue ZhangDerek LiGayathri SrinivasanMontaser ShaheenRobert Hromas

phase ii trialoncologyparp inhibitor

Results of a Phase II, Open-Label Pilot Study Evaluating the Safety and Activity of Liposomal Irinotecan (Nal-Iri) in Combination With 5-Fu and Oxaliplatin (Nalirifox) in Preoperative Treatment of Pancreatic Adenocarcinoma (Neo-Nal-Iri Study).. Journal of Clinical Oncology (2024)

Thomas J. GeorgeSherise C. RogersIbrahim NassourIlyas SahinBrian Hemendra RamnaraignJesus FabregasKathryn HitchcockTuo LinGonghao LiuRobert ZloteckiOmar Roger KayalehAnita Ahmed TurkZ. Hugh FanKaren Bullock RussellDavid L. DeRemerJi-Hyun LeeSteven J. Hughes

pancreatic cancerphase iineo-nal-iri studycancer carecancer managementgastrointestinal surgerycervical cancerhealth sciencescancer researchsurgical oncologycancer immunotherapycancer treatmentdrug safetyopen-label pilot studypharmacologyradiation oncologypreoperative treatmentoncologyclinical researchpancreatic surgerymedicinal research

Abstract 2186: An Exploratory Analysis of the Intestinal Microbiome in Neoadjuvant Chemotherapy for Pancreatic Cancer. Cancer Research (2023)

Sherise RogersRyan ThomasBrain RamnaraignIlyas SahinJesus FabregasKaren RussellSteven HughesIbrahim NassourKathyrn HitchcockOmar KayalehAnita TurkJi-Hyun LeeDavid DeRemerCarmen AllegraThomas George

microbiomeintestinal microbiomemedical microbiologycancer careradiation oncologycancer researchclinical microbiologypancreatic canceroncologyneoadjuvant chemotherapyexploratory analysiscancer treatmentcancer biologyhealth sciences

Abstract B138: Pharmacodynamics-Driven Phase 2 Trial of Talazoparib in Patients With Advanced Solid Tumors and Aberrations in Genes Involved in Dna Damage Response. Molecular Cancer Therapeutics (2023)

Brian KoGeraldine H O'Sullivan CoyneAbdul Rafeh NaqashThomas J GeorgeDavid DeRemerLarry RubinsteinJennifer ZlottDeborah WilskerDonna KetchumStephanie RunkleKatherine V Ferry-GalowRalph E ParchmentNaoko TakebeSarah ShinAndrea R VothJiuping JiS. Percy IvyJames H DoroshowAlice P Chen

gene therapymedicineenzyme inhibitionpharmacologycancer caredna damage responseradiation oncologycancer researchmolecular cancerpharmacotherapyclinical trialsoncologymedicinal researchdna repaircancer treatmentdrug trialsadvanced solid tumors

Abstract Pr018: Feasibility of Serial Microbiome Collection in a Multi-Site Neoadjuvant Pancreatic Cancer Clinical Trial Allowing for a Diverse Patient Population. Cancer Epidemiology Biomarkers & Prevention (2023)

Sherise C. RogersIbrahim NassourRyan ThomasIlyas SahinBrian RamnaraignKaren RussellSteven HughesKathryn HitchcockOmar KayalehAnita TurkJi-Hyun LeeDavid DeRemerCarmen AllegraThomas George

public healthtreatment and preventionmicrobial diversityoutcomes researchcancer carecancer researchclinical microbiologypancreatic cancerclinical populationscancer preventionserial microbiome collectionclinical trialsdiverse patient populationoncologyglobal healthclinical researchhealth sciences

1
2
3
4
5
9
10 / page

David DeRemer

Clinical Professor

University of Florida

Affiliations

College of Pharmacy

Pharmacotherapy and Translational Research

David Deremer is currently serving as a College Of Pharmacy Clinical Professor at University of Florida.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

David DeRemer

University of Florida

Clinical Professor

You can click a keyword to filter the displayed items

Video Presentations

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 4816: Racial Disparities in Adjunctive Supportive Care Medication Use in Pancreatic Cancer Patients. Cancer Research (2024)

Olga M. Trejos KweyeteYi GuoSherise C. RogersLisa ScartonDavid L. DeRemerChardae L. WhitnerDiana J. WilkieJohn M. Allen

medicinecancer carecancer researchpancreatic cancerhealth care disparitiesoncologyracial disparitiessupportive care

Abstract 4834: Racial Disparities in Pain and Psychiatric Medication Use in Patients With Metastatic Colorectal Cancer. Cancer Research (2024)

John M. AllenOlga M. Trejos KweyeteYi GuoSherise C. RogersLisa ScartonDavid L. DeRemerChardae WhitnerDiana J. Wilkie

A Phase Ib/II Study of Atezolizumab Plus Tivozanib in Pancreatic, Gallbladder, and Bile Duct Malignancies.. Journal of Clinical Oncology (2024)

Brian Hemendra RamnaraignJi-Hyun LeeIlyas SahinSherise C. RogersRyan M. ThomasCarmen J. AllegraDavid L. DeRemerThomas J. GeorgeJonathan Alexander Chatzkel

CAPIVASERTIB: A Novel Akt Inhibitor Approved for Hormone-Receptor-Positive, Her-2-Negative Metastatic Breast Cancer. Annals of Pharmacotherapy (2024)

Alexa J. LuboffDavid L. DeRemer

Implementation of a Pharmacogenetic Panel‐Based Test for Pharmacotherapy‐Based Supportive Care in an Adult Oncology Clinic. Clinical and Translational Science (2024)

adult oncology clinicpharmacologypharmacogenetic panel-based testpharmacotherapyoncologyclinical researchpharmaceutical carepharmacotherapy-based supportive care

Phase II Trial of the Parp Inhibitor, Niraparib, in Bap1 and Other Dna Damage Response Pathway-Deficient Neoplasms. JCO Precision Oncology (2024)

phase ii trialoncologyparp inhibitor

Abstract 2186: An Exploratory Analysis of the Intestinal Microbiome in Neoadjuvant Chemotherapy for Pancreatic Cancer. Cancer Research (2023)

Sherise RogersRyan ThomasBrain RamnaraignIlyas SahinJesus FabregasKaren RussellSteven HughesIbrahim NassourKathyrn HitchcockOmar KayalehAnita TurkJi-Hyun LeeDavid DeRemerCarmen AllegraThomas George

Sherise C. RogersIbrahim NassourRyan ThomasIlyas SahinBrian RamnaraignKaren RussellSteven HughesKathryn HitchcockOmar KayalehAnita TurkJi-Hyun LeeDavid DeRemerCarmen AllegraThomas George

1
2
3
4
5
9
10 / page

Similar Faculty Members

Mitch A. Phelps

Institution

Ohio State University

future medicinal chemistry

pharmacology

Jill Kolesar

Institution

University of Kentucky

oncology

pharmacology

David Claxton

Institution

Pennsylvania State University

metabolomics

hematological malignancies

Christopher R Cogle

Institution

University of Florida

hematology

medicine

Ashkan Emadi

Institution

West Virginia University

brain tumor research

acute leukemia

Brenda W. Cooper

Institution

Case Western Reserve University

medicine

hematology

Ivo Abraham

Institution

University of Arizona

health system

medicine

Alexander E Perl

Institution

University of Pennsylvania

oncogene

hematological malignancies

Anand Jillella

Institution

Augusta University

hematology

medicine

Rosemarie Mick

Institution

University of Pennsylvania

oncology

radiation oncology

Similar Faculty Members

Mitch A. Phelps

Institution

Ohio State University

future medicinal chemistry

pharmacology

Jill Kolesar

Institution

University of Kentucky

oncology

pharmacology

David Claxton

Institution

Pennsylvania State University

metabolomics

hematological malignancies

Christopher R Cogle

Institution

University of Florida

hematology

medicine

Ashkan Emadi

Institution

West Virginia University

brain tumor research

acute leukemia

Brenda W. Cooper

Institution

Case Western Reserve University

medicine

hematology

Ivo Abraham

Institution

University of Arizona

health system

medicine

Alexander E Perl

Institution

University of Pennsylvania

oncogene

hematological malignancies

Anand Jillella

Institution

Augusta University

hematology

medicine

Rosemarie Mick

Institution

University of Pennsylvania

oncology

radiation oncology